If you are interested in glycans and comfortable in python, I highly recommend glycowork: quick to learn, accessible, and well supported open source code for working with glycans and accessing cutting edge developments from the Bojar group

$SRPT pricing highlights problem with accelerated approval - you cant charge premium prices for unproven products At the same time, patients want early access to promising therapies The solution seems simple: anything short of full approval comes with price set by regulators

Early-stage startup projections in a nutshell

We could not be more excited to announce this important milestone. Building a recognizable brand is often overlooked by fast-growing biotech companies. This is a big step forward for Octagon Therapeutics

Octagon's updated website is live. Nice to be able to tell the world a little more about what we are doing. And no, we did not sign on aging former pro-wrestlers to our Business Advisory Board! Octagon Therapeutics #autoimmunedisease #inflammation octagontherapeutics.com

If “progressive leaders” like Elizabeth Warren wanted to supercharge American innovation they would not stop talking about the ridiculous government restrictions of the H1B lottery system. These innovators help us build the greatest economy in the world. Reform this shit system asap.

Woah.

Tim Wakefield's daughter throwing out the first pitch at the home opener. Wakefield was the ultimate team player. If you haven't, do yourself a favor and read "Knuckler", his autobiography. Dude had a LOT of grit.

Great fun and a great conversation

Woah. edwardasare.com/meet-the-dibab…

Very excited to have thoughtful venture investors joining us on our journey @octagontx slaterfund.com/octagon-seed-r…

I'm very excited about Octagon's expanded Board of Directors. These veteran leaders are going to help power our novel immunomodulatory medicines into the clinic. octagontherapeutics.com/about

Treatment approaches that deplete or suppress healthy immune cells put patients at risk. Octagon Therapeutics is developing immunomodulatory therapies that reset immune homeostasis while sparing protective immunity! endpts.com/infections-are…

We're excited to announce the addition of Liguo (Vicky) Wu to our core team! Dr. Wu brings a wealth of expertise in translational immunology and will play an important role in leading our R&D efforts. #glycoimmunology #autoimmune #inflammation

Tune in tomorrow for a new episode of Biorasi's Few & Far Between podcast. Host Chris O'Brien welcomes Isaac Stoner, CEO at Octagon Therapeutics, to the podcast to zoom in on #autoimmune disease, the role of the CEO, and effective funding strategies. #YourGoToCRO #clinicaltrials #CROs

Had a blast shooting this podcast with Biorasi

Octagon is hiring! See link below linkedin.com/posts/octagont…

Thanks Johannes Fruehauf🇺🇦 and LabCentral for the opportunity to highlight our work at Octagon Therapeutics in this wide-ranging conversion! youtube.com/watch?v=GNPDuC…

All the interesting science people have left Twitter. What's left is a cesspool of ragebait and borderline inappropriate ads. Find me on bluesky bsky.app/profile/isaacb…